article thumbnail

Top 14 BioPharmaceutical Consultants & Consulting Firms

Jake Jorgovan

BioPharma Consultants : Specializes in marketing, strategy, and corporate development services for the biotech and pharmaceutical industries, offering solutions from product launch plans to commercial support for fundraising.

article thumbnail

Top 9 Due Diligence Consultants & Consulting Firms

Jake Jorgovan

Their approach often emphasizes due diligence, strategic planning, and seamless integration to maximize value creation. Alacrita Alacrita is a consultancy firm in the pharmaceutical and biotech industries, specializing in comprehensive due diligence services.

Biotech 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top 11 Life Science Consultants & Consulting Firms

Jake Jorgovan

Herspiegel Consulting : Recognized for its excellence in commercial strategy, Herspiegel Consulting focuses on innovative solutions for pharmaceutical and biotech companies, with a strong track record in product launches and commercial execution. Assisting in capturing opportunities across the value chain. market goals for its clients.

article thumbnail

Is the Potential Threat of Shareholder Activism Heightened by the Pandemic?

LaVoie Health Science Blog

As biotech and pharmaceutical companies work to stabilize their clinical programs and business strategies during the significant disruptions caused by the COVID-19 pandemic, one of the potential challenges that public companies may encounter is aggressive moves by activist investors looking to leverage the economic turmoil for corporate takeovers.

Biotech 52
article thumbnail

LHS Expert Insights: ESG Issues for Life Science Innovators

LaVoie Health Science Blog

As investments into sustainable companies and funds have surged to new highs, how can biotech and life science companies best position themselves with this burgeoning group of investors. Are there investment/business risks in not pursuing an ESG reporting approach? However, it has it unique characteristics to address from an ESG standpoint.